Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials

Thrombosis Research

Volumn 123, Issue 1, 2008, Pages 24-34

  Xing, Katharine He ^a,b   Morrison, Gareth ^a,c   Lim, Wendy ^a   Douketis, James ^a   Odueyungbo, Adefowope ^a   Crowther, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Arthroplasty; Oral anticoagulant; Venous thrombosis; Warfarin

Indexed keywords

WARFARIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; DEEP VEIN THROMBOSIS; HUMAN; INCIDENCE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADULT; AGE FACTORS; AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HUMANS; INCIDENCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; VENOUS THROMBOSIS; WARFARIN;

EID: 54049134398     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.05.005     Document Type: Review

References (64)

1. Cohen S.H., Ehrlich G.E., Kauffman M.S., and Cope C. Thrombophlebitis following knee surgery. J Bone Joint Surg Am 55 1 (1973) 106-112
2. Stulberg B.N., Insall J.N., Williams G.W., and Ghelman B. Deep-vein thrombosis following total knee replacement: an analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am 66 2 (1984) 194-201
3. Lynch A.F., Bourne R.B., Rorabeck C.H., Rankin R.N., and Donald A. Deep-vein thrombosis and continuous passive motion after total knee arthroplasty. J Bone Joint Surg Am 70 1 (1988) 11-14
4. Stringer M.D., Steadman C.A., Hedges A.R., Thomas E.M., Morley T.R., and Kakkar V.V. Deep vein thrombosis after elective knee surgery. J Bone Joint Surg Br 71 3 (1989) 492-497
5. Turpie A.G.G., Levine M.N., Hirsh J., Carter C.J., Jay R.M., Powers P.J., et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315 15 (1986) 925-929
6. Hull R.D., Raskob G.E., Gent M., McLoughlin D., Julian D., Smith F.C., et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 263 17 (1990) 2313-2317
7. Lassen M.R., Borris L.C., Christiansen H.M., Boll K.L., Eiskjaer S.P., Nielsen B.W., et al. Prevention of thromboembolism in 190 hip arthroplasties; comparison of LMW heparin and placebo. Acta Orthop Scand 62 1 (1991) 33-38
8. Hoek J.A., Nurmohamed M.T., Hamelynck K.J., Marti R.K., Knipscheer H.C., ten Cate H., et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 67 1 (1992) 28-32
9. Clagett G.P., Anderson Jr. F.A., Heit J., Levine M.N., and Wheeler H.B. Prevention of venous thromboembolism. Chest 108 4 Suppl (1995) 312S-334S
10. National Institutes of Health Consensus Development Panel. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 256 6 (1986) 744-749
11. Lieberman J.R., and Geerts W.H. Prevention of venous thromboembolism after total hip and knee arthroplasty. J. Bone Joint Surg Am 76 8 (1994) 1239-1250
12. Weinmann E.E., and Salzman E.W. Deep-vein thrombosis. N Engl J Med 331 24 (1994) 1630-1641
13. Geerts W.H., Heit J.A., Clagett G.P., Pineo G.F., Colwell C.W., Anderson Jr. F.A., et al. Prevention of venous thromboembolism. Chest 119 1 Suppl (2001) 132S-175S
14. McGinn T., Wyer P.C., Newman T.B., Keitz S., and Leipzig R. For GG, Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 171 11 (2004) 1369-1373
15. Maclure M., and Willett W.C. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol 126 2 (1987) 161-169
16. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 1 (1996) 1-12
17. Schulz K.F. Assessing allocation concealment and blinding in randomized controlled trials: why bother?. ACP J Club 132 2 (2000) A11-A12
18. Fisher R.A. The goodness of fit of regression formulae, and the distribution of regression coefficients. J R Stat Soc 85 (1922) 597-612
19. Rothman K.J. Modern epidemiology (1986), MA Little and Brown, Boston
20. Robins J., Breslow N., and Greenland S. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large strata models. Biometrics 42 (1986) 311-323
21. Vives M.J., Hozack W.J., Sharkey P.F., Moriarty L., Sokoloff B., and Rothman R.H. Fixed minidose versus-adjusted low-dose warfarin after total joint arthroplasty: a randomized prospective study. J Arthroplast 16 8 (2001) 1030-1037
22. Colwell Jr. C.W., Collis D.K., Paulson R., McCutchen J.W., Bigler G.T., Lutz S., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 81 7 (1999) 932-940
23. Samama C.M., Vray M., Barre J., Fiessinger J.N., Rosencher N., Lecompte T., et al. SACRE Study Investigators. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med 162 19 (2002) 2191-2196
24. Lotke P.A., Palevsky H., Keenan A.M., Meranze S., Steinberg M.E., Ecker M.L., et al. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop 324 (1996) 251-258
25. RD Heparin Arthroplasty Group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am 76 8 (1994) 1174-1185
26. Bailey J.P., Kruger M.P., Solano F.X., Zajko A.B., and Rubash H.E. Prospective randomized trial of sequential compression devices vs low-dose warfarin for deep venous thrombosis prophylaxis in total hip arthroplasty. J Arthroplast 6 Suppl (1991) S29-S35
27. Kaempffe F.A., Lifeso R.M., and Meinking C. Intermittent pneumatic compression versus coumadin. Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop 269 (1991) 89-97
28. Woolson S.T., and Watt J.M. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg Am 73 4 (1991) 507-512
29. Paiement G., Wessinger S.J., Waltman A.C., and Harris W.H. Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplast 2 1 (1987) 23-26
30. Francis C.W., Marder V.J., Evarts C.M., and Yaukoolbodi S. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. JAMA 249 3 (1983) 374-378
31. Kornberg A., Francis C.W., Pellegrini Jr. V.D., Gabriel K.R., and Marder V.J. Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis. Circulation 88 2 (1993) 454-460
32. Colwell Jr. C.W., Berkowitz S.D., Lieberman J.R., Comp P.C., Ginsberg J.S., Paiement G., et al. EXULT B Study Group. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am 87 10 (2005) 2169-2177
33. Francis C.W., Berkowitz S.D., Comp P.C., Lieberman J.R., Ginsberg J.S., Paiement G., et al. EXULT A Study Group. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 349 18 (2003) 1703-1712
34. Francis C.W., Davidson B.L., Berkowitz S.D., Lotke P.A., Ginsberg J.S., Lieberman J.R., et al. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. Ann Intern Med 137 8 (2002) 648-655
35. Fitzgerald Jr. R.H., Spiro T.E., Trowbridge A.A., Gardiner Jr. G.A., Whitsett T.L., O'Connell M.B., et al. Enoxaparin Clinical Trial Group. Prevention of venous thromboembolic disease following primary total knee arthroplasty. J Bone Joint Surg Am 83-A 6 (2001) 900-906
36. Hull R.D., Pineo G.F., Francis C., Bergqvist D., Fellenius C., Soderberg K., et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. Arch Intern Med 160 14 (2000) 2199-2207
37. Comp P.C., Voegeli T., McCutchen J.W., Skoutakis V.A., Trowbridge A., and Overdyke W.L. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement. Orthopedics 21 10 (1998) 1123-1128
38. Francis C.W., Pellegrini Jr. V.D., Totterman S., Boyd Jr. A.D., Marder V.J., Liebert K.M., et al. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am 79 9 (1997) 1365-1372
39. Heit J.A., Berkowitz S.D., Bona R., Cabanas V., Corson J.D., Elliott C.G., et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Thromb Haemost 77 1 (1997) 32-38
40. Francis C.W., Pellegrini Jr. V.D., Leibert K.M., Totterman S., Azodo M.V., Harris C.M., et al. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement. Thromb Haemost 75 5 (1996) 706-711
41. Hamulyak K., Lensing A.W., van der Meer J., Smid W.M., van Ooy A., and Hoek J.A. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement?. Thromb Haemost 74 6 (1995) 1428-1431
42. Hull R., Raskob G., Pineo G., Rosenbloom D., Evans W., Mallory T., et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 329 19 (1993) 1370-1376
43. Feller J.A., Parkin J.D., Phillips G.W., Hannon P.J., Hennessy O., and Huggins R.M. Prophylaxis against venous thrombosis after total hip arthroplasty. Aust N Z J Surg 62 8 (1992) 606-610
44. Francis C.W., Pellegrini Jr. V.D., Marder V.J., Totterman S., Harris C.M., Gabriel K.R., et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 267 21 (1992) 2911-2915
45. Anderson D.R., Gross M., Robinson K.S., Petrie D., Leighton R., Stanish W., et al. Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications: the Postarthroplasty Screening Study (PASS). Chest 114 2 Suppl Evidence (1998) 119S-122S
46. Leclerc J.R., Geerts W.H., Desjardins L., Laflamme G.H., L'Esperance B., Demers C., et al. Prevention of venous thromboembolism after knee arthroplasty. Ann Intern Med 124 7 (1996) 619-626
47. Jaffer A.K., Barsoum W.K., Krebs V., Hurbanek J.G., Morra N., and Brotman D.J. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty. Mayo Clin Proc 80 6 (2005) 732-738
48. Jarrett P.M., Ritchie I.K., Albadran L., Glen S.K., Bridges A.B., and Ely M. Do thigh tourniquets contribute to the formation of intra-operative venous emboli?. Acta Orthop Belg 70 3 (2004) 253-259
49. Nagashima M., Wauke K., Ogawa R., and Yoshino S. The association between the use of tourniquet during operation and the development of pulmonary thromboembolism and deep vein thrombosis. J Nippon Med Sch 70 2 (2003) 86-87
50. Wauke K., Nagashima M., Kato N., Ogawa R., and Yoshino S. Comparative study between thromboembolism and total knee arthroplasty with or without tourniquet in rheumatoid arthritis patients. Arch Orthop Trauma Surg 122 8 (2002) 442-446
51. Parmet J.L., Berman A.T., Horrow J.C., Harding S., and Rosenberg H. Thromboembolism coincident with tourniquet deflation during total knee arthroplasty. Lancet 341 8852 (1993) 1057-1058
52. Abdel-Salam A., and Eyres K.S. Effects of tourniquet during total knee arthroplasty. A prospective randomised study. J Bone Joint Surg Br 77 2 (1995) 250-253
53. Fukuda A., Hasegawa M., Kato K., Shi D., Sudo A., and Uchida A. Effect of tourniquet application on deep vein thrombosis after total knee arthroplasty. Arch Orthop Trauma Surg 127 8 (2007) 671-675
54. Wakankar H.M., Nicholl J.E., Koka R., and D'Arcy J.C. The tourniquet in total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg Br 81 1 (1999) 30-33
55. Harvey E.J., Leclerc J., Brooks C.E., and Burke D.L. Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty. J Arthroplast 12 3 (1997) 291-296
56. Stulberg B.N., Insall J.N., Williams G.W., and Ghelman B. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am 66 2 (1984) 194-201
57. Angus P.D., Nakielny R., and Goodrum D.T. The pneumatic tourniquet and deep venous thrombosis. J Bone Joint Surg Br 65 3 (1983) 336-339
58. Simon M.A., Mass D.P., Zarins C.K., Bidani N., Gudas C.J., and Metz C.E. The effect of a thigh tourniquet on the incidence of deep venous thrombosis after operations on the fore part of the foot. J Bone Joint Surg Am 64 2 (1982) 188-191
59. Fahmy N.R., and Patel D.G. Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg Am 63 3 (1981) 461-465
60. White R.H., Gettner S., Newman J.M., Trauner K.B., and Romano P.S. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 343 24 (2000) 1758-1764
61. Munin M.C., Rudy T.E., Glynn N.W., Crossett L.S., and Rubash H.E. Early inpatient rehabilitation after elective hip and knee arthroplasty. JAMA 279 11 (1998) 847-852
62. Buehler K.O., D'Lima D.D., Petersilge W.J., Colwell Jr. C.W., and Walker R.H. Late deep venous thrombosis and delayed weightbearing after total hip arthroplasty. Clin Orthop 361 (1999) 123-130
63. Pearse E.O., Caldwell B.F., Lockwood R.J., and Hollard J. Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism. J Bone Joint Surg Br 89 3 (2007) 316-322
64. Douketis J.D., Eikelboom J.W., Quinlan D.J., Willan A.R., and Crowther M.A. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 162 13 (2002) 1465-1471